BCI
XGN icon

Brinker Capital Investments’s Exagen XGN Stock Holding History

Brinker Capital Investments’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-99,115
Closed -$269K – 1405
2022
Q3 		$269K Buy
99,115
+8,519
+9% +$47.5K 0.01% 1161
2022
Q2 		$520K Sell
90,596
-2,622
-3% -$15.3K 0.01% 964
2022
Q1 		$749K Buy
93,218
+21,825
+31% +$188K 0.01% 900
2021
Q4 		$830K Sell
71,393
-48,846
-41% -$572K 0.01% 892
2021
Q3 		$1.8M Hold
120,239
– – 0.03% 576
2021
Q2 		$1.8M Buy
+120,239
New +$1.84M 0.02% 633

Other funds holding XGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Brinker Capital Investments's XGN Position: Q4 2022 in Review

Brinker Capital Investments sold out of Exagen (XGN) in Q4 2022, closing a stake of 99,115 shares — an estimated $269K sold.

Brinker Capital Investments first reported a position in XGN in Q2 2021 and held it in 6 quarters. The position peaked at $1.8M in Q3 2021. 31 funds tracked by Wall St. Rank hold XGN as of Q4 2022.

  • Brinker Capital Investments reported no remaining Exagen position as of Q4 2022 after selling out during the quarter.
  • Brinker Capital Investments sold 99,115 Exagen shares in Q4 2022, an estimated $269K.
  • Brinker Capital Investments first reported a position in Exagen in Q2 2021 and held it in 6 quarters.
  • Brinker Capital Investments's Exagen position peaked at $1.8M in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Exagen as of Q4 2022.

Based on Brinker Capital Investments's 13F filing for Q4 2022, filed 6 Feb 2023.